NCT05477576
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05477576
Title Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy (ACTION-1)
Acronym ACTION-1
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors RayzeBio, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | FRA | ESP | CAN | BRA | BEL

Facility Status City State Zip Country Details
Research Facility Phoenix Arizona 85054 United States Details
Research Facility Duarte California 91010 United States Details
Research Facility Irvine California 92663 United States Details
Research Facility Los Angeles California 90095 United States Details
Research Facility Palo Alto California 94305 United States Details
Research Facility San Francisco California 94143 United States Details
Research Facility New Haven Connecticut 06510 United States Details
Research Facility Washington D.C. District of Columbia 20010 United States Details
Research Facility Jacksonville Florida 32224 United States Details
Research Facility Miami Florida 33165 United States Details
Research Facility Tampa Florida 33607 United States Details
Research Facility Atlanta Georgia 30322 United States Details
Research Facility Iowa City Iowa 52242 United States Details
Research Facility Lexington Kentucky 40536 United States Details
Research Facility Glen Burnie Maryland 21061 United States Details
Research Facility Boston Massachusetts 02118 United States Details
Research Facility Boston Massachusetts 02215 United States Details
Research Facility Troy Michigan 48098 United States Details
Research Facility Rochester Minnesota 55905 United States Details
Research Facility St Louis Missouri 63110 United States Details
Research Facility Omaha Nebraska 68130 United States Details
Research Facility New York New York 10029 United States Details
Research Facility New York New York 10065 United States Details
Research Facility Cleveland Ohio 44106 United States Details
Research Facility Columbus Ohio 43221 United States Details
Research Facility Portland Oregon 97239 United States Details
Research Facility Philadelphia Pennsylvania 19104 United States Details
Research Facility Pittsburgh Pennsylvania 15232 United States Details
Research Facility Nashville Tennessee 37232 United States Details
Research Facility Houston Texas 77030 United States Details
Research Facility Salt Lake City Utah 84112 United States Details
Research Facility Seattle Washington 98109 United States Details
Research Facility Brussels Belgium Details
Research Facility Leuven Belgium Details
Research Facility Roeselare Belgium Details
Research Facility Brasília Brazil Details
Research Facility Rio de Janeiro Brazil Details
Research Facility São Paulo Brazil Details
Research Facility London Ontario Canada Details
Research Facility Toronto Ontario M4N 3M5 Canada Details
Research Facility Montreal Quebec Canada Details
Research Facility Clichy France Details
Research Facility Lille France Details
Research Facility Montpellier France Details
Research Facility Nantes France Details
Research Facility Vandœuvre-lès-Nancy France Details
Research Facility Villejuif France Details
Research Facility Amsterdam Netherlands Details
Research Facility Maastricht Netherlands Details
Research Facility Utrecht Netherlands Details
Research Facility Seoul South Korea Details
Research Facility Barcelona Spain Details
Research Facility Madrid Spain Details
Research Facility Zaragoza Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field